Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DLCB65
|
|||
| Drug Name |
IONIS-DNM2-2.5Rx
|
|||
| Drug Type |
Antisense oligonucleotide
|
|||
| Indication | Centronuclear myopathy [ICD-11: 8C72.01] | Phase 2 | [1] | |
| Company |
Ionis Pharmaceuticals
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | DNM2 messenger RNA (DNM2 mRNA) | Target Info | Inhibitor | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Ionis Pharmaceuticals. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.